Purdue Pharma’s former president Richard Sackler, MD, knew his company’s opioid painkiller OxyContin was being abused, but still pushed sales to physicians and tried to divert the blame to patients ...

PARIS -- A unit of French advertising giant Publicis Groupe SA agreed Thursday to pay $350 million to settle claims it helped OxyContin maker Purdue Pharma fuel the opioid epidemic in the United ...

STAMFORD — U.S. states’ claims in Purdue Pharma’s bankruptcy case total approximately $2.2 trillion. Any settlement amount reached with the company, however, will likely be for far less. The company ...

NEW YORK, Oct 21 (Reuters) - More than 99% of bankrupt drugmaker Purdue Pharma's creditors voted to accept a $7.4 billion settlement of legal claims related to the company's sales of addictive opioid ...

A federal bankruptcy judge said on Friday he will approve a restructuring plan for drugmaker Purdue Pharma that includes a $7.4 billion settlement resolving claims that it fueled the U.S. opioid ...

Add Yahoo as a preferred source to see more of our stories on Google. Attorneys have filed more than 360 claims for West Virginia children born with opioid dependency after the approval of Purdue ...

Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer fully protects the company’s owners, members of the Sackler families, from ...

RICHMOND, Va. (WRIC) — Richmond advocates are celebrating the monumental opioid settlement reached with OxyContin maker Purdue Pharma on Friday. On Friday, Nov. 14, a federal bankruptcy court judge ...

A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma's latest deal to settle thousands of lawsuits over the toll of opioids that includes some money for ...

NEW YORK – A federal bankruptcy judge said on Friday he will approve a restructuring plan for drugmaker Purdue Pharma that includes a $7.4 billion settlement resolving claims that it fueled the U.S.

(NEW YORK) -- Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer fully protects the company’s owners, members of the Sackler ...